Showing results (141-150 of 1,648) with videos related to

Sort By:
Pageof 165
Hepatology International|November 10, 2016
Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver diseaseNozomu Wada, Akinobu Takaki, Fusao Ikeda, et al.
Hepatology International|March 22, 2017
Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolizationSangheun Lee, Jung Hyun Kang, Do Young Kim, et al.
Hepatology International|February 23, 2017
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosisMi Young Jeon, Hye Won Lee, Seung Up Kim, et al.
Hepatology International|December 9, 2016
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapyRebecca Lee, Shyam Kottilil, Eleanor Wilson
Hepatology International|January 19, 2017
Virus-induced hepatocellular carcinoma with special emphasis on HBVMing Wang, Dong Xi, Qin Ning
Hepatology International|September 10, 2022
Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic reviewJonathan Li, Vivian Wu, Calvin Q Pan
Hepatology International|May 1, 2016
APASL consensus statements and recommendation on treatment of hepatitis CMasao Omata, Tatsuo Kanda, Lai Wei, et al.
Pageof 165